SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $4,550,000 | -24.1% | 80,090 | 0.0% | 0.05% | -22.9% |
| Q1 2021 | $5,995,000 | +1159.5% | 80,090 | +1356.2% | 0.07% | +1066.7% |
| Q4 2020 | $476,000 | +41.2% | 5,500 | 0.0% | 0.01% | +20.0% |
| Q3 2020 | $337,000 | -67.4% | 5,500 | -77.9% | 0.01% | -64.3% |
| Q2 2020 | $1,034,000 | +2147.8% | 24,850 | +1453.1% | 0.01% | +1300.0% |
| Q1 2020 | $46,000 | -61.0% | 1,600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $118,000 | -47.6% | 1,600 | 0.0% | 0.00% | -50.0% |
| Q3 2019 | $225,000 | -23.2% | 1,600 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $293,000 | +14.9% | 1,600 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $255,000 | +65.6% | 1,600 | -0.3% | 0.00% | +50.0% |
| Q4 2018 | $154,000 | -32.2% | 1,605 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $227,000 | -9.6% | 1,605 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $251,000 | +93.1% | 1,605 | +99.4% | 0.00% | +100.0% |
| Q1 2018 | $130,000 | -2.3% | 805 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $133,000 | +166.0% | 805 | +0.6% | 0.00% | – |
| Q3 2017 | $50,000 | -21.9% | 800 | 0.0% | 0.00% | -100.0% |
| Q2 2017 | $64,000 | +12.3% | 800 | 0.0% | 0.00% | – |
| Q1 2017 | $57,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Finepoint Capital LP | 475,600 | $15,362,000 | 5.31% |
| Integral Health Asset Management, LLC | 412,257 | $13,316,000 | 2.74% |
| Palo Alto Investors LP | 851,409 | $27,501,000 | 2.40% |
| Boxer Capital, LLC | 1,094,000 | $35,336,000 | 2.24% |
| DAFNA Capital Management LLC | 180,306 | $5,824,000 | 1.59% |
| Ikarian Capital, LLC | 250,000 | $8,075,000 | 1.47% |
| Bellevue Group AG | 2,973,178 | $96,034,000 | 1.36% |
| SECTOR GAMMA AS | 118,476 | $3,827,000 | 0.86% |
| Artal Group S.A. | 450,000 | $14,535,000 | 0.78% |
| Diametric Capital, LP | 19,393 | $626,000 | 0.46% |